In Europe, ultrasound (US) is the diagnostic gold standard for the visualisation of parotid gland disorders. While high-resolution B-mode US reliably visualises focal lesions, its diagnostic capacity to distinguish tumour entities or to characterise diffuse lesions remains poor. Strain elastography (SE) and shear wave elastography (SWE) are novel imaging techniques that provide additional information about tissue elasticity. SE analyses the strain or displacement in response to force or compression and, therefore, shows the relative tissue elasticity within a selected region of interest (ROI). Recent studies suggest that SE might be able to predict parotid gland malignancy. In SWE, push pulses generate localised displacements within an ROI that describes mechanical tissue properties expressed in absolute values. Recent studies indicate that SWE can predict tissue fibrosis in different organs. This review article highlights the current role of SE and SWE modalities in diffuse and focal changes of the parotid gland.

Keywords:
Ultrasound, Strain elastography, Shear wave elastography, Parotid gland
1.
Hofauer B, et al: Swelling of the submandibular and parotid glands: a description of possible differential diagnoses (in German). HNO 2016;64:333-348.
2.
Frey H: Realtime elastography. A new ultrasound procedure for the reconstruction of tissue elasticity (in German). Radiologe 2003;43:850-855.
3.
Wojcinski S, et al: Multicenter study of ultrasound real-time tissue elastography in 779 cases for the assessment of breast lesions: improved diagnostic performance by combining the BI-RADS®-US classification system with sonoelastography. Ultraschall Med 2010;31:484-491.
4.
Yi A, et al: Sonoelastography for 1,786 non-palpable breast masses: diagnostic value in the decision to biopsy. Eur Radiol 2012;22:1033-1040.
5.
Bojunga J, et al: Real-time elastography for the differentiation of benign and malignant thyroid nodules: a meta-analysis. Thyroid 2010;20:1145-1150.
6.
Friedrich-Rust M, et al: Evaluation of strain elastography for differentiation of thyroid nodules: results of a prospective DEGUM multicenter study. Ultraschall Med 2016;37:262-270.
7.
Zhai L, et al: An integrated indenter-ARFI imaging system for tissue stiffness quantification. Ultrason Imaging 2008;30:95-111.
8.
Nightingale K, et al: Acoustic radiation force impulse imaging: in vivo demonstration of clinical feasibility. Ultrasound Med Biol 2002;28:227-235.
9.
Friedrich-Rust M, et al: Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat 2012;19:e212-e219.
10.
Friedrich-Rust M, et al: Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur J Radiol 2012;81:e325-e331.
11.
Zhan J, et al: Acoustic radiation force impulse imaging (ARFI) for differentiation of benign and malignant thyroid nodules - a meta-analysis. Eur J Radiol 2015;84:2181-2186.
12.
Liu B, et al: Elastography by acoustic radiation force impulse technology for differentiation of benign and malignant breast lesions: a meta-analysis. J Med Ultrason (2001) 2016;43:47-55.
13.
Cornec D, et al: The differential diagnosis of dry eyes, dry mouth, and parotidomegaly: a comprehensive review. Clin Rev Allergy Immunol 2015;49:278-287.
14.
Hofauer B, et al: Liposomal local therapy as treatment for sicca symptoms in patients with primary Sjögren's syndrome (in German). HNO 2013;61:921-927.
15.
Vitali C, et al: Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558.
16.
Knopf A, et al: Rheumatic disorders affecting the head and neck: underestimated diseases. Rheumatology (Oxford) 2011;50:2029-2034.
17.
Shiboski SC, et al: American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012;64:475-487.
18.
Cornec D, et al: Contribution of salivary gland ultrasonography to the diagnosis of Sjögren's syndrome: toward new diagnostic criteria? Arthritis Rheum 2013;65:216-225.
19.
Hocevar A, et al: Ultrasonographic changes of major salivary glands in primary Sjögren's syndrome. Diagnostic value of a novel scoring system. Rheumatology (Oxford) 2005;44:768-772.
20.
Kalk WW, et al: Parotid sialography for diagnosing Sjögren syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:131-137.
21.
Salaffi F, et al: Ultrasonography of salivary glands in primary Sjögren's syndrome: a comparison with contrast sialography and scintigraphy. Rheumatology (Oxford) 2008;47:1244-1249.
22.
Hofauer B, et al: Sonoelastographic modalities in the evaluation of salivary gland characteristics in Sjögren's syndrome. Ultrasound Med Biol 2016;42:2130-2139.
23.
Niemela RK, et al: Ultrasonography of salivary glands in primary Sjögren's syndrome. A comparison with magnetic resonance imaging and magnetic resonance sialography of parotid glands. Rheumatology (Oxford) 2004;43:875-879.
24.
Milic V, et al: Ultrasonography of major salivary glands could be an alternative tool to sialoscintigraphy in the American-European Classification Criteria for primary Sjögren's syndrome. Rheumatology (Oxford) 2012;51:1081-1085.
25.
Carotti M, et al: Ultrasonography of the salivary glands: the role of grey-scale and colour/power Doppler. Clin Exp Rheumatol 2014;32(suppl 80):S61-S70.
26.
Wierzbicka M, et al: Sonoelastography - a useful adjunct for parotid gland ultrasound assessment in patients suffering from chronic inflammation. Med Sci Monit 2014;20:2311-2317.
27.
Knopf A, et al: Diagnostic utility of Acoustic Radiation Force Impulse (ARFI) imaging in primary Sjögren's syndrome. Eur Radiol 2015;25:3027-3034.
28.
Hocevar A, et al: Ultrasonographic changes of major salivary glands in primary Sjögren's syndrome. Evaluation of a novel scoring system. Eur J Radiol 2007;63:379-383.
29.
Chen S, et al: Virtual touch quantification of the salivary glands for diagnosis of primary Sjögren syndrome. J Ultrasound Med 2016;35:2607-2613.
30.
Zhang S, et al: Assessment of the stiffness of major salivary glands in primary Sjögren's syndrome through quantitative acoustic radiation force impulse imaging. Ultrasound Med Biol 2016;42:645-653.
31.
Mantsopoulos K, et al: Applicability of shear wave elastography of the major salivary glands: values in healthy patients and effects of gender, smoking and pre-compression. Ultrasound Med Biol 2015;41:2310-2318.
32.
Epstein JB, et al: Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin 2012;62:400-422.
33.
Obinata K, et al: Changes in parotid gland morphology and function in patients treated with intensity-modulated radiotherapy for nasopharyngeal and oropharyngeal tumors. Oral Radiol 2014;30:135-141.
34.
Badea I, et al: Acoustic Radiation Force Impulse quantitative elastography: a new noninvasive technique for the evaluation of parotid glands. A preliminary study in controls and in patients with irradiated nasopharyngeal carcinoma. Med Ultrason 2015;17:308-314.
35.
Kalużny J, et al: Shear wave elastography: a new noninvasive tool to assess the intensity of fibrosis of irradiated salivary glands in head and neck cancer patients. Biomed Res Int 2014;2014:157809.
36.
Seifert G, et al: WHO International Histological Classification of Tumours. Tentative histological classification of salivary gland tumours. Pathol Res Pract 1990;186:555-581.
37.
Knopf A, et al: A critical review of 20 years of parotid gland surgery. Acta Otolaryngol 2016;136:711-716.
38.
Koch M, Zenk J, Iro H: Long-term results of morbidity after parotid gland surgery in benign disease. Laryngoscope 2010;120:724-730.
39.
Spiro JD, Spiro RH: Cancer of the parotid gland: role of 7th nerve preservation. World J Surg 2003;27:863-867.
40.
Mantsopoulos K, et al: Evolution and changing trends in surgery for benign parotid tumors. Laryngoscope 2015;125:122-127.
41.
Knopf A, et al: Multimodal ultrasonographic characterisation of parotid gland lesions - a pilot study. Eur J Radiol 2012;81:3300-3305.
42.
Mansour N, et al: Evaluation of parotid gland lesions with standard ultrasound, color duplex sonography, sonoelastography, and acoustic radiation force impulse imaging - a pilot study. Ultraschall Med 2012;33:283-288.
43.
Dumitriu D, et al: Ultrasonographic and sonoelastographic features of pleomorphic adenomas of the salivary glands. Med Ultrason 2010;12:175-183.
44.
Dumitriu D, et al: Real-time sonoelastography of major salivary gland tumors. AJR Am J Roentgenol 2011;197:W924-W930.
45.
Bhatia KS, et al: Evaluation of real-time qualitative sonoelastography of focal lesions in the parotid and submandibular glands: applications and limitations. Eur Radiol 2010;20:1958-1964.
46.
Mansour N, et al: Multimodal ultrasonographic pathway of parotid gland lesions. Ultraschall Med 2015, Epub ahead of print.
47.
Klintworth N, et al: Sonoelastography of parotid gland tumours: initial experience and identification of characteristic patterns. Eur Radiol 2012;22:947-956.
48.
Itoh A, et al: Breast disease: clinical application of US elastography for diagnosis. Radiology 2006;239:341-350.
49.
Bhatia KS, et al: Shear wave elastography of focal salivary gland lesions: preliminary experience in a routine head and neck US clinic. Eur Radiol 2012;22:957-965.
50.
Matsuzuka T, et al: Stiffness of salivary gland and tumor measured by new ultrasonic techniques: virtual touch quantification and IQ. Auris Nasus Larynx 2015;42:128-133.
51.
Badea AF, et al: Solid parotid tumors: an individual and integrative analysis of various ultrasonographic criteria. A prospective and observational study. Med Ultrason 2013;15:289-298.
52.
Wei X, et al: Evaluation of microvascularization in focal salivary gland lesions by contrast-enhanced ultrasonography (CEUS) and Color Doppler sonography. Clin Hemorheol Microcirc 2013;54:259-271.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.